LEGAL NOTICES

Print this page Text Size AAA

Bayer, Schering-Plough, and GSK Web Site Legal Notice

Bayer Pharmaceuticals Corporation (BAYER), GlaxoSmithKline (GSK), and Schering-Plough Corporation offer products and services to diagnose, prevent, and treat disease. Their prescription medicines for use by health care professionals are regulated by government agencies in each of the countries in which they do business, such as the Food and Drug Administration in the United States (U.S.) or the Committee on Safety of Medicine in the United Kingdom. These regulations often restrict the prescribing information that can be disclosed to the public so that you need to consult with your health care professional. You may also need to visit other health care Web sites to find out more about prescription products.

This Web site has been developed as a service of BAYER, GSK, and Schering-Plough Corporation. Like any other service, in spite of our best efforts, the information in this Web site may become out of date over time. Nothing on this Web site should be construed as the giving of advice or the making of a recommendation and it should not be relied on as the basis for any decision or action. It is important that you rely only on the advice of a health care professional to advise you on your specific situation. BAYER, GSK, and Schering-Plough Corporation accept no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on this Web site. These materials are provided "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. Some jurisdictions do not allow the exclusion of implied warranties, so the above exclusion may not apply to you.

This U.S.-based Web site may link you to other Web sites on the Internet, including the Web sites for BAYER, GSK, and Schering-Plough Corporation affiliates in other countries. BAYER, GSK, and Schering-Plough Corporation take no responsibility for information found on third-party Web sites outside their control. While BAYER, GSK, and Schering-Plough Corporation attempt to provide links only to third-party Web sites that comply with all applicable laws and regulations and BAYER, GSK, and Schering-Plough Corporation standards, please understand that the content on these third-party Web sites is subject to change without notice to BAYER, GSK, or Schering-Plough Corporation. BAYER, GSK, and Schering-Plough Corporation therefore cannot be responsible for, and accept no liability for, any information or opinion contained in any third-party Web site.

Nothing on this Web site constitutes an invitation or offer to invest or deal in the securities or ADRs of BAYER, GSK, or Schering-Plough Corporation. In particular, actual results and developments may be materially different from any forecast, opinion, or expectation expressed on this Web site and the past performance of the price of securities must not be relied on as a guide to their future performance.

Copyright and Intellectual Property

BAYER, GSK, and Schering-Plough Corporation hereby authorize you to copy materials published on this Web site for non-commercial use only, provided any copy of these materials that you make shall retain all copyright and other proprietary notices and any disclaimer contained thereon and on this Web site. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise, any license or right under any patent or trademark of GlaxoSmithKline or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any BAYER copyright, GSK copyright, or Schering-Plough Corporation copyright.

Trademarks and service marks owned by or licensed to BAYER, GSK, and Schering-Plough Corporation are presented as italicized typefaces, such as Seretide or Tums. British and American spellings are used, depending on the author or source of the information. BAYER, GSK, and Schering-Plough Corporation claim no ownership in, nor any affiliation with, any third-party trademarks appearing in this Web site. Such third-party trademarks are used only to identify the products and services of their respective owners, and no sponsorship or endorsement on the part of BAYER, GSK, or Schering-Plough Corporation should be inferred from the use of these marks.

Should any viewer of a BAYER, GSK, or Schering-Plough Corporation published document respond with information including feedback data such as questions, comments, suggestions, or the like regarding the content of any such BAYER, GSK, or Schering-Plough Corporation material, such information shall be deemed to be nonconfidential and we shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation. We shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever including, but not limited, to developing, manufacturing, and marketing products incorporating such information. © 2006 Bayer Pharmaceuticals Corporation. All Rights Reserved. GlaxoSmithKline and Schering-Plough Corporation. Updated February 2, 2006.

Back to Top

 

 
 

LEVITRA (vardenafil HCI) is a prescription medicine that is used to treat erectile dysfunction (ED).

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Important Safety and Dosing Information

LEVITRA (vardenafil HCI) is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level.

As with all ED drugs, there is a rare risk of an erection lasting longer than four hours. To avoid long-term injury, seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases. In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicine, including LEVITRA) reported a sudden decrease or loss of vision in one or both eyes, or a sudden decrease or loss in hearing, sometimes with ringing in the ears and dizziness. It is not possible to determine whether these events are related directly to these medicines or to other factors. If you experience any of these symptoms, stop taking PDE5 inhibitors, including LEVITRA, and call a doctor right away.

Discuss your medical conditions, including heart problems, and medications, including alpha blockers prescribed for prostate problems or high blood pressure, with your doctor to ensure LEVITRA is right for you and that you are healthy enough for sexual activity. LEVITRA is not recommended for men with uncontrolled high blood pressure.

The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking alpha blockers, your doctor may start you on a lower dose of LEVITRA. In patients taking certain medications such as ritonavir, indinavir, saquinavir, atazanavir, ketoconazole, itraconazole, erythromycin and clarithromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended.

In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see complete Prescribing Information, which includes the patient information, for 2.5-mg, 5-mg, 10-mg, and 20-mg
LEVITRA® (vardenafil HCl).
[Requires Adobe® Reader® - click here to download]

  Adobe is a registered trademark of Adobe Systems Incorporated.
This site is intended for U.S. residents only.

©2004-2009 Bayer Pharmaceuticals Corporation. All Rights Reserved. GlaxoSmithKline and Schering Corporation.